State of Wyoming’s Tarsus Pharmaceuticals TARS Stock Holding History

State of Wyoming’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-363	Closed	-$14.7K	–	2050
2025 Q2	$14.7K	Buy	+363	New	+$16.3K	﹤0.01%	1740

Other funds holding TARS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

State of Wyoming's TARS Position: Q3 2025 in Review

State of Wyoming sold out of Tarsus Pharmaceuticals (TARS) in Q3 2025, closing a stake of 363 shares — an estimated $14.7K sold.

State of Wyoming first reported a position in TARS in Q2 2025 and held it in 1 quarter. The position peaked at $14.7K in Q2 2025. 220 funds tracked by Wall St. Rank hold TARS as of Q3 2025.

State of Wyoming reported no remaining Tarsus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
State of Wyoming sold 363 Tarsus Pharmaceuticals shares in Q3 2025, an estimated $14.7K.
State of Wyoming first reported a position in Tarsus Pharmaceuticals in Q2 2025 and held it in 1 quarter.
State of Wyoming's Tarsus Pharmaceuticals position peaked at $14.7K in Q2 2025.
220 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2025.

Based on State of Wyoming's 13F filing for Q3 2025, filed 4 Nov 2025.